Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology.
作者信息
Kovacs Gabor G, Grinberg Lea T, Halliday Glenda, Alafuzoff Irina, Dugger Brittany N, Murayama Shigeo, Forrest Shelley L, Martinez-Valbuena Ivan, Tanaka Hidetomo, Kon Tomoya, Yoshida Koji, Jaunmuktane Zane, Spina Salvatore, Nelson Peter T, Gentleman Steve, Alegre-Abarrategui Javier, Serrano Geidy E, Paes Vitor Ribeiro, Takao Masaki, Wakabayashi Koichi, Uchihara Toshiki, Yoshida Mari, Saito Yuko, Kofler Julia, Rodriguez Roberta Diehl, Gelpi Ellen, Attems Johannes, Crary John F, Seeley William W, Duda John E, Keene C Dirk, Woulfe John, Munoz David, Smith Colin, Lee Edward B, Neumann Manuela, White Charles L, McKee Ann C, Thal Dietmar R, Jellinger Kurt, Ghetti Bernardino, Mackenzie Ian R A, Dickson Dennis W, Beach Thomas G
机构信息
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco (UCSF), San Francisco, California, USA.
出版信息
Mov Disord. 2024 Dec;39(12):2173-2179. doi: 10.1002/mds.30028. Epub 2024 Oct 3.
Abstract
摘要
相似文献
1
Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology.基于生物标志物的α-突触核蛋白病研究方法：神经病理学的经验教训
Mov Disord. 2024 Dec;39(12):2173-2179. doi: 10.1002/mds.30028. Epub 2024 Oct 3.
2
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联：一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.
3
Molecular beacon-based detection of circulating microRNA-containing extracellular vesicle as an α-synucleinopathy biomarker.基于分子信标的循环 microRNA 含外泌体检测作为α-突触核蛋白病生物标志物。
Sci Adv. 2024 May 17;10(20):eadl6442. doi: 10.1126/sciadv.adl6442. Epub 2024 May 15.
4
α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.α-突触核蛋白放射性示踪剂的开发和体内成像：最新进展和新视角。
Mov Disord. 2022 May;37(5):936-948. doi: 10.1002/mds.28984. Epub 2022 Mar 15.
5
Soluble and Insoluble Lysates from the Human A53T Mutant α-Synuclein Transgenic Mouse Model Induces α-Synucleinopathy Independent of Injection Site.来自人A53T突变α-突触核蛋白转基因小鼠模型的可溶性和不溶性裂解物可诱导α-突触核蛋白病，且与注射部位无关。
Int J Mol Sci. 2025 Jun 28;26(13):6254. doi: 10.3390/ijms26136254.
6
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies.适体结合足迹可区分不同神经核蛋白病的α-突触核蛋白纤维多态性。
Nucleic Acids Res. 2024 Aug 12;52(14):8072-8085. doi: 10.1093/nar/gkae544.
7
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.α-突触核蛋白种籽扩增检测在α-突触核蛋白病中的诊断价值：系统评价和荟萃分析。
Parkinsonism Relat Disord. 2022 Nov;104:99-109. doi: 10.1016/j.parkreldis.2022.10.007. Epub 2022 Oct 19.
8
Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort.光学相干断层扫描揭示α-突触核蛋白病中的视网膜结构异常：来自帕多瓦- CESNE队列的见解。
J Neural Transm (Vienna). 2025 Apr 15. doi: 10.1007/s00702-025-02918-y.
9
Neuropathology and molecular diagnosis of Synucleinopathies.神经病理学和神经核蛋白病的分子诊断。
Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z.
10
Post-Illumination Pupil Response as a Biomarker for Cognition in α-Synucleinopathies.光照后瞳孔反应作为α-突触核蛋白病认知功能的生物标志物
J Parkinsons Dis. 2022;12(2):593-598. doi: 10.3233/JPD-212775.
引用本文的文献
1
Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.重新审视帕金森病的定义和分类：来自两个新兴生物学框架的见解。
J Neural Transm (Vienna). 2025 Sep 4. doi: 10.1007/s00702-025-03013-y.
2
Lewy-MSA hybrid fold drives distinct neuronal α-synuclein pathology.路易体-多系统萎缩混合折叠驱动独特的神经元α-突触核蛋白病变。
Commun Biol. 2025 Jun 16;8(1):929. doi: 10.1038/s42003-025-08355-7.
3
Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center data.利用美国国家阿尔茨海默病协调中心的数据研究路易体前驱性痴呆中的性别差异。
Alzheimers Dement. 2025 May;21(5):e70275. doi: 10.1002/alz.70275.
4
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.阿尔茨海默病神经病理学及其通过体液和影像生物标志物进行的评估。
Mol Neurodegener. 2025 Mar 14;20(1):33. doi: 10.1186/s13024-025-00819-y.
5
Determinants of alpha-synuclein pathogenesis in Parkinson's disease.帕金森病中α-突触核蛋白发病机制的决定因素。
Neural Regen Res. 2026 Apr 1;21(4):1568-1569. doi: 10.4103/NRR.NRR-D-24-01357. Epub 2025 Feb 24.
6
Implementing a tridimensional diagnostic framework for personalized medicine in neurodegenerative diseases.为神经退行性疾病的个性化医疗实施三维诊断框架。
Alzheimers Dement. 2025 Feb;21(2):e14591. doi: 10.1002/alz.14591.
7
Initial biological classification of Lewy body diseases: No consensus on terminology.路易体疾病的初步生物学分类：术语尚无共识。
Alzheimers Dement. 2025 Feb;21(2):e14449. doi: 10.1002/alz.14449. Epub 2024 Dec 28.
本文引用的文献
1
Association of CSF α-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer's Disease Neuroimaging Initiative study.脑脊液α-突触核蛋白种子扩增检测阳性与疾病进展及认知衰退的关联：一项阿尔茨海默病神经影像学倡议纵向研究
Alzheimers Dement. 2024 Dec;20(12):8444-8460. doi: 10.1002/alz.14276. Epub 2024 Oct 20.
2
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.脑脊液α-突触核蛋白种子扩增检测在进行性核上性麻痹和皮质基底节综合征中的评估
Mov Disord. 2024 Dec;39(12):2285-2291. doi: 10.1002/mds.30019. Epub 2024 Sep 20.
3
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale.团队科学方法在全球范围内揭示单基因帕金森病。
Mov Disord. 2024 Oct;39(10):1868-1873. doi: 10.1002/mds.29925. Epub 2024 Jul 30.
4
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset.血浆蛋白质组学鉴定出可预测帕金森病的生物标志物，其可在症状出现前 7 年预测疾病。
Nat Commun. 2024 Jun 18;15(1):4759. doi: 10.1038/s41467-024-48961-3.
5
Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.穿越α-突触核蛋白病的复杂性：发病机制、异质性和未来展望的深入了解。
Neuron. 2024 Sep 25;112(18):3029-3042. doi: 10.1016/j.neuron.2024.05.017. Epub 2024 Jun 10.
6
Computer-Based Evaluation of α-Synuclein Pathology in Multiple System Atrophy as a Novel Tool to Recognize Disease Subtypes.基于计算机的多系统萎缩 α-突触核蛋白病理学评估作为一种识别疾病亚型的新工具。
Mod Pathol. 2024 Aug;37(8):100533. doi: 10.1016/j.modpat.2024.100533. Epub 2024 Jun 7.
7
A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.阿尔茨海默病神经影像学倡议中α-突触核蛋白种子扩增测定的横断面研究：患病率及与阿尔茨海默病生物标志物和认知功能的相关性。
Alzheimers Dement. 2024 Aug;20(8):5114-5131. doi: 10.1002/alz.13858. Epub 2024 May 21.
8
Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.伴有以淀粉样β蛋白为主的阿尔茨海默病神经病理改变的多系统萎缩
Brain Commun. 2024 Apr 17;6(3):fcae141. doi: 10.1093/braincomms/fcae141. eCollection 2024.
9
Parkinson's Disease and Dementia with Lewy Bodies: One and the Same.帕金森病与路易体痴呆：一回事。
J Parkinsons Dis. 2024;14(3):383-397. doi: 10.3233/JPD-240002.
10
Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing.帕金森病患者脑组织的转录组学研究：批量和单细胞 RNA 测序的比较。
Mol Neurobiol. 2024 Nov;61(11):8996-9015. doi: 10.1007/s12035-024-04124-5. Epub 2024 Apr 5.
Zotero 插件